Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009

We have analyzed our experience regarding use of tyrosine kinase inhibitors especially imatinib mesylate in patients of chronic myeloid leukemia-chronic phase over last 7 years at our center (2002-2009). The object was to report long-term efficacy (hematological, cytogenetic and molecular) and toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, M. B., Agarwal, Usha M., Rathi, Shonali S., Masurkar, Sangeeta, Zaveri, Bindi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902625/
https://www.ncbi.nlm.nih.gov/pubmed/24516310
http://dx.doi.org/10.4103/0971-5851.123741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902625/
https://www.ncbi.nlm.nih.gov/pubmed/24516310
http://dx.doi.org/10.4103/0971-5851.123741

Ejemplares similares